UBS Group AG - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 50 filers reported holding CENTURY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,458
-24.4%
16,729
+19.4%
0.00%
Q2 2023$44,284
+73.9%
14,014
+91.0%
0.00%
Q1 2023$25,459
-9.0%
7,337
+34.5%
0.00%
Q4 2022$27,9745,453
+16940.6%
0.00%
Q1 2022$0
-100.0%
32
-99.4%
0.00%
Q4 2021$88,000
+633.3%
5,528
+1046.9%
0.00%
Q3 2021$12,000
-60.0%
482
-53.3%
0.00%
Q2 2021$30,0001,0320.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,307,407$2,614,8140.81%
Casdin Capital, LLC 3,206,380$6,412,7600.71%
Parametrica Management Ltd 27,840$55,6800.09%
Avidity Partners Management LP 1,098,500$2,197,0000.09%
Deep Track Capital, LP 543,008$1,086,0160.04%
HARBOURVEST PARTNERS LLC 29,018$58,0360.02%
CORNERCAP INVESTMENT COUNSEL INC 51,520$103,0400.02%
Baker Brothers Advisors 1,149,340$2,298,6800.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 165,000$330,0000.01%
FEDERATED HERMES, INC. 615,982$1,231,9640.00%
View complete list of CENTURY THERAPEUTICS INC shareholders